The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeen Regulatory News (SEEN)

Share Price Information for Seeen (SEEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: -0.65 (-14.77%)
Spread: 0.50 (14.286%)
Open: 4.40
High: 4.40
Low: 3.75
Prev. Close: 4.40
SEEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment Confirmation

27 May 2022 07:00

RNS Number : 0018N
SEEEN PLC
27 May 2022
 

 

SEEEN plc

("SEEEN" or the "Company")

 

Confirmation of Board appointment

and

Director Dealing

 

SEEEN plc (AIM: SEEEN), the video optimisation platform company offering proprietary technology products and services to help creators, brands and publishers drive value from their video assets, is pleased to confirm the appointment of Charles Burdick as an independent Non-executive Director with immediate effect.

Charles Burdick has agreed to waive Board fees for this financial year and in exchange has been granted an option to acquire 200,000 ordinary shares in the Company at an exercise price of 30 pence, approximately 94% above the closing mid-market price of an ordinary share in the Company on 26 May 2022. These options will vest 1/3rd on the first anniversary, 1/3rd on the second anniversary and 1/3rd on the third anniversary.

Enquiries:

SEEEN

Patrick DeSouza, Chairman

Tel: +44 (0)7775 701 838

Akiko Mikumo, Co-CEO

David Anton, Co-CEO

Adrian Hargrave, CFO

Panmure Gordon

(Financial Adviser, Nominated Adviser & Joint Broker)

Tel: +44 (0)20 7886 2500

Alina Vaskina / Harriette Johnson (Corporate Advisory)

Rupert Dearden (Corporate Broking)

Dowgate Capital (Joint Broker)

Tel: +44 (0)20 3903 7721

Stephen Norcross

 

Additional Information

In accordance with the AIM Rules, the following information required to be disclosed in relation to Charles Burdick is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.

Full name and age

Charles James Burdick, aged 70

Current beneficial shareholding in the Group

Nil

Current Directorships

Nil

Former Directorships (previous five years)

Trivon AG (trading as Virgin Connect Russia)

Orion Telekom Holdings B.V.

Disclosure required under paragraph (g) (v) and (vii) of Schedule Two of the AIM Rules for Companies

Mr Burdick was appointed as a director of Bally Total Fitness Holding Corporation in or around January 2006. In or around August 2007 Mr Burdick resigned from the Board and in August 2007 the company filed for Chapter 11 protection from creditors under a pre-packaged reorganization plan which was supported by holders of its bond issues. The court filings showed the company had $396.8 of assets and $761.3 million of debt at the end of its prior fiscal year.

Mr Burdick was appointed as a director of Kaupthing Singer and Friedlander Limited in or around February 2006 and in October 2008 the company entered into administration, which is within 12 months of Charles's resignation. Mr Burdick resigned from the Board in October 2008 and the company was dissolved in December 2021. The deficiency as regards creditors was approximately £2.4m.

NOTIFICATION OF TRANSACTION OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS

The notifications below, made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail in respect of the transactions described above. 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Charles Burdick

2

Reason for the notification

a)

Position/status:

Non-executive Director

b)

Initial notification/Amendment:

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

SEEEN plc

b)

LEI:

213800RQVRMW2KRORN22

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares

 

GB00BK6SHS41

b)

Nature of the transaction:

Grant of share option award

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

Nil

200,000

d)

Aggregated information:

· Aggregated volume:

· Price:

 

 n/a (single transaction)

e)

Date of the transaction:

27 May 2022

f)

Place of the transaction:

 Outside of a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANSKAFFAEFA
12
Date   Source Headline
1st Mar 20247:00 amRNSPartnership with the American 7s Football League
2nd Feb 20247:00 amRNSDirector dealings
1st Feb 20247:00 amRNSTrading Update and Board Change
18th Jan 20247:00 amRNSPartnership with the London Broncos
29th Sep 20237:00 amRNSInterim Results
26th Sep 202311:57 amRNSHolding(s) in Company
6th Sep 20237:00 amRNSTechnology Day
24th Aug 20237:00 amRNSDirector dealing
26th Jul 202312:23 pmRNSResult of AGM
26th Jul 20237:00 amRNSLaunch of CreatorSuite 2.0
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
7th Jun 20237:00 amRNSAttendance at UK Investor Show
18th May 20237:00 amRNSAppointment of Non-Executive Director and CFO
6th Feb 20237:00 amRNSTrading Update, Customer Win and Board Change
11th Jan 202312:22 pmRNSHolding(s) in Company
4th Jan 20231:15 pmRNSHolding(s) in Company
30th Dec 20221:00 pmRNSTotal Voting Rights
28th Dec 20227:00 amRNSHolding(s) in Company
28th Dec 20227:00 amRNSHolding(s) in Company
23rd Dec 20229:44 amRNSResult of GM and Open Offer
7th Dec 20226:25 pmRNSFundraise and other matters
7th Dec 20226:22 pmRNSAppointment of Nominated Adviser and Joint Broker
8th Nov 20225:27 pmRNSHolding(s) in Company
28th Oct 20225:13 pmRNSHolding(s) in Company
29th Sep 20227:00 amRNSInterim Results
26th Aug 20225:07 pmRNSHolding(s) in Company
25th Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSDirector/PDMR Shareholding
28th Jul 20224:59 pmRNSResult of AGM
11th Jul 20227:01 amRNSCustomer Win - Daily Mail
11th Jul 20227:00 amRNSCEO Appointment
6th Jul 20227:00 amRNSCustomer Wins
30th Jun 20227:00 amRNSFinal Results and Notice of AGM
31st May 20227:00 amRNSHolding(s) in Company
31st May 20227:00 amRNSDirector Shareholding and Notice of Results
27th May 20227:00 amRNSBoard Appointment Confirmation
25th Apr 20224:41 pmRNSSecond Price Monitoring Extn
25th Apr 20224:36 pmRNSPrice Monitoring Extension
7th Apr 20227:00 amRNSContract Wins
16th Mar 20227:00 amRNSDirector Changes, Business Update
23rd Feb 20227:00 amRNSStrategic Partnership with Kinetiq, Inc
3rd Feb 20227:00 amRNSTrading Update
27th Jan 20227:00 amRNSContract Wins and Notice of Trading Update
2nd Dec 20217:00 amRNSContract Wins and 3Q Trading Update
29th Sep 20217:00 amRNSHalf-year Report
20th Sep 20217:00 amRNSNotice of Results
4th Aug 20217:00 amRNS1H Trading Update and Director Change
29th Jul 20217:00 amRNSResult of AGM
29th Jun 20217:00 amRNSFinal Results and Notice of AGM
17th Jun 202111:00 amRNSNotice of Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.